NCT05089058

Brief Summary

Intrusive memories are sensory memories of a traumatic event(s) that spring to mind involuntarily, evoke strong emotions, and disrupt functioning in daily life. Previous research has demonstrated that a brief cognitive intervention can prevent the development of intrusive memories as well as reduce the number of intrusive memories of long-standing trauma. Initial pilot work (using case studies) with women in Iceland indicates that the intervention is acceptable and feasible. This exploratory pilot trial will compare remote delivery of the intervention (i.e. brief, digitally delivered imagery-competing task intervention, n = 12) to an attention-placebo control condition (i.e., brief, digitally delivered relaxation exercise task; n = 12). We will explore whether (relative to the control condition) the intervention: (i) reduces the number of intrusive memories (primary outcome), and (ii) improves other symptoms and functioning. This study is funded by the OAK foundation (OCAY-18-442) and the Strategic Research and Development Program: Societal Challenges in Iceland (200095-5601).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 22, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2022

Completed
Last Updated

November 17, 2022

Status Verified

November 1, 2022

Enrollment Period

8 months

First QC Date

October 5, 2021

Last Update Submit

November 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of intrusive memories of traumatic event(s)

    Number of intrusive memories of traumatic event(s) recorded in a brief daily diary for 7 days

    Week 5

Secondary Outcomes (15)

  • Number of intrusive memories of traumatic event(s)

    Baseline, Week 1, Week 12 and Week 24

  • The Posttraumatic Stress Disorder Checklist 5 (PCL-5)

    Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  • The Patient Health Questionnaire-9 (PHQ-9)

    Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  • The Generalized Anxiety Disorder-7 scale (GAD-7)

    Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  • Characteristics of intrusive memories

    Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  • +10 more secondary outcomes

Other Outcomes (5)

  • Credibility/expectancy scale.

    First intervention session = 7 days from baseline, Week 1 and Week 5

  • Vividness of visual imagery question (adapted from VVIQ-2)

    First intervention session = 7 days from baseline

  • Acceptability and feasibility

    Week 1, 1-month, and 3-month follow-ups

  • +2 more other outcomes

Study Arms (2)

Brief cognitive task (delivered digitally)

EXPERIMENTAL
Behavioral: Brief, digitally delivered imagery-competing task intervention package, comprised of:

Brief relaxation exercise task (delivered digitally)

PLACEBO COMPARATOR
Behavioral: Brief, digitally delivered relaxation task intervention, comprised of:

Interventions

Two sessions guided (remotely) by a researcher. Sessions comprised of: (i) task procedure: a memory cue followed by playing imagery-competing computer game task with mental rotation instructions. Monitoring of intrusive memories to select hotspot cue, and which intrusion to target. (ii) accompanying information, including rationale for the brief cognitive task. (iii) option to use the brief cognitive task after the session (self-administered); option to engage in up to 6 guided booster sessions supported by a researcher.

Brief cognitive task (delivered digitally)

Brief, digitally delivered relaxation task intervention, comprised of: Two sessions guided (remotely) by a researcher. Sessions comprised of: (i) relaxation exercise task using instruction components from progressive muscle relaxation (ii) accompanying information, including rationale for the brief relaxation exercise task. (iii) option to use the brief relaxation exercise task after the session (self-administered); option to engage in up to 6 guided booster sessions supported by a researcher.

Brief relaxation exercise task (delivered digitally)

Eligibility Criteria

Age18 Years - 69 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged: 18-69 (at time of enrollment to cohort study)
  • Able to speak and read study materials in Icelandic or English
  • Willing to be contacted remotely and having access to a smartphone or computer
  • Experienced intrusive memories in past month (PCL-5 item 1 score is ≥ 2)
  • Experienced 2 or more intrusive memories of a traumatic event in the past week
  • Willing to monitor intrusive memories in everyday life
  • Willing and able to complete remote study sessions

You may not qualify if:

  • Suicide risk indicated in the initial assessment (response of 'nearly every day' to item 9 on PHQ-9) and by responses on MINI during follow-up telephone risk assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iceland, Sæmundargata 12

Reykjavik, 102, Iceland

Location

Study Officials

  • Andri Björnsson

    University of Iceland

    PRINCIPAL INVESTIGATOR
  • Emily Holmes

    Uppsala University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 5, 2021

First Posted

October 22, 2021

Study Start

November 1, 2021

Primary Completion

June 23, 2022

Study Completion

November 4, 2022

Last Updated

November 17, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share
Access Criteria
Anonymised research data will be made available on Open Science Framework (OSF) indefinitely. OSF is an open source web application that is freely accessible to public and scientific community.

Locations